Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
This is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003). Its aim is to examine the safety and long-term efficacy of CYB003 in participants with MDD.
Sponsor: Cybin IRL Limited
Check if you qualify for this major depressive disorder clinical trial in Chicago, IL
If you're searching for major depressive disorder treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.